Mechanisms of Glucocorticoid‐Resistant Asthma a

Abstract: The term “steroid‐ or glucocorticoid‐resistant (GR) asthma” has been used to describe a group of asthmatics who demonstrate persistent airway obstruction and inflammation despite treatment with high doses of systemic glucocorticoids (GCs). There are at least two forms of GR asthma. The first group of patients has an acquired form of GC resistance. Analysis of their bronchoalveolar lavage (BAL) cells indicates an extremely high level of IL‐2 and IL‐4 gene expression as compared to BAL cells from GC‐sensitive asthmatics. The incubation of T cells from normal individuals with the combination of IL‐2 and IL‐4 induces GC receptor binding defects, and concomitant GC receptor β expression, in their cells. Similar abnormalities in GC receptor binding defects can be detected in freshly isolated cells from type 1 GR asthmatics, but this defect is reversible when their cells are cultured in the absence of IL‐2 and IL‐4. The second group involves patients with primary GC resistance who do not develop side effects on high‐dose GCs and have very low numbers of GC receptors in their mononuclear cells. This defect is irreversible in culture and affects their T cells as well as non‐T cells. The current studies provide new insights into mechanisms by which inflammation induces GC resistance and how defects in the GC receptor may contribute to chronic inflammation, creating the vicious cycle leading to chronic inflammatory diseases.

[1]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[2]  S. Szefler,et al.  A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. , 1996, Journal of immunology.

[3]  D. Klemm,et al.  716 Alterations in glucocorticoid(GC) receptor(R) binding to DNA contributes to steroid resistant (SR) asthma , 1996 .

[4]  S. Szefler,et al.  244 Superantigens alter glucocorticoid receptor binding (GCR) affinity in vitro , 1996 .

[5]  I. Adcock,et al.  Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[6]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[7]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[8]  P. Barnes,et al.  Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo. , 1995, The Journal of clinical investigation.

[9]  S. Szefler,et al.  Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. , 1995, American journal of respiratory and critical care medicine.

[10]  G. Chrousos,et al.  Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.

[11]  I. Adcock,et al.  Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. , 1995, Journal of immunology.

[12]  R. Martin,et al.  Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma , 1995, The Journal of experimental medicine.

[13]  J. Arm,et al.  Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. , 1994, American journal of respiratory cell and molecular biology.

[14]  R. Zitnik,et al.  Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. , 1994, American journal of respiratory cell and molecular biology.

[15]  A. Ray,et al.  Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Szefler,et al.  Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. , 1994, The Journal of clinical investigation.

[17]  W. Pratt.  The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. , 1993, The Journal of biological chemistry.

[18]  S. Szefler,et al.  Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. , 1993, Journal of immunology.

[19]  S. Durham,et al.  Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. , 1993, The American review of respiratory disease.

[20]  D. Toft,et al.  Steroid receptors and their associated proteins. , 1993, Molecular endocrinology.

[21]  M. Puliti,et al.  Effect of corticosteroid treatment on interleukin‐1 and tumour necrosis factor secretion by monocytes from subjects with asthma , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[23]  E. Gelfand,et al.  Steroid-resistant asthma: immunologic and pharmacologic features. , 1992, The Journal of allergy and clinical immunology.

[24]  J. Tsai,et al.  Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. , 1991, The American review of respiratory disease.

[25]  S. Szefler,et al.  Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. , 1991, The American review of respiratory disease.

[26]  K. Constantine,et al.  Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. , 1991, The Journal of clinical investigation.

[27]  M. Karin,et al.  Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.

[28]  K. Yamamoto,et al.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.

[29]  P. Venge,et al.  Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. , 1990, The American review of respiratory disease.

[30]  T. Clark,et al.  Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma. , 1989, The Journal of clinical investigation.

[31]  J. Fauvel,et al.  Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis. , 1989, The Journal of biological chemistry.

[32]  E. Thompson,et al.  Abnormal glucocorticoid receptor gene and mRNA in primary cortisol resistance. , 1989, Journal of steroid biochemistry.

[33]  R. Flower.  Lipocortin and the mechanism of action of the glucocorticoids , 1988, British journal of pharmacology.

[34]  D. Cockcroft,et al.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. , 1987, The Journal of allergy and clinical immunology.

[35]  R. Evans,et al.  Primary structure and expression of a functional human glucocorticoid receptor cDNA , 1985, Nature.

[36]  J. Douglas,et al.  Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. , 1984, Clinical science.

[37]  G. Chrousos,et al.  Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. , 1982, The Journal of clinical investigation.

[38]  A. B. Kay,et al.  Corticosteroid-resistant chronic asthma and monocyte complement receptors. , 1981, Clinical and experimental immunology.

[39]  G. Crompton,et al.  Corticosteroid resistance in chronic asthma. , 1981 .

[40]  D. Jelliffe,et al.  BREAST MILK SUBSTITUTES AND THE W.H.O. CODE , 1981, The Lancet.

[41]  C. Bloomfield,et al.  IN-VITRO GLUCOCORTICOID STUDIES FOR PREDICTING RESPONSE TO GLUCOCORTICOID THERAPY IN ADULTS WITH MALIGNANT LYMPHOMA , 1980, The Lancet.

[42]  F. C. Lowell,et al.  Steroid Resistance in Bronchial Asthma , 1968 .